Sandoz Tries An Authorized Generic Argument To Relaunch At-Risk Skelaxin

A temporary restraining order is blocking Sandoz's generic version of King's muscle relaxant, but CorePharma's launch of an authorized generic means the TRO should be lifted, Sandoz argues.